Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Sevilla, Sevilla, España.
Mini Rev Med Chem. 2013 Jan;13(1):58-69.
This article presents the potential of PLGA nanoparticles for the oral administration of drugs. Different strategies are used to improve oral absorption of these nanoparticles. These strategies are based on modification of nanoparticle surface properties. They can be achieved either by coating the nanoparticle surface with stabilizing hydrophilic bioadhesive polymers or surfactants, or by incorporating biodegradable copolymers containing a hydrophilic moiety. Some substances such as chitosan, vitamin E, methacrylates, lectins, lecithins, bile salts and RGD molecules are employed for this purpose. Of especial interest are nanoparticles production methods and, in order to improve oral bioavailability, the mechanism of each additive.
本文介绍了 PLGA 纳米粒作为药物经口给药的潜力。为了提高这些纳米粒的口服吸收,采用了不同的策略。这些策略基于对纳米粒表面性质的修饰。可以通过用稳定的亲水性生物黏附聚合物或表面活性剂包被纳米粒表面,或者通过掺入含有亲水性部分的可生物降解共聚物来实现。为此,使用了壳聚糖、维生素 E、甲基丙烯酸酯、凝集素、卵磷脂、胆汁盐和 RGD 分子等物质。特别关注的是纳米粒的生产方法,以及为了提高口服生物利用度,每种添加剂的作用机制。
Mini Rev Med Chem. 2013-1
ACS Appl Mater Interfaces. 2015-7-9
Drug Deliv. 2014-5-28
J Control Release. 2006-12-1
Colloids Surf B Biointerfaces. 2014-11-1
Crit Rev Ther Drug Carrier Syst. 2016
Int J Biol Macromol. 2012-12-19
Int J Ophthalmol. 2018-6-18
ACS Appl Mater Interfaces. 2017-3-21
Polymer (Guildf). 2015-12-2
Int J Nanomedicine. 2014-10-28